Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease
A registered clinical trial evaluating characteristics and survival outcomes in hepatocellular carcinoma comparing viral hepatitis–associate…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma
This is an ongoing clinical trial sponsored by Nanfang Hospital/Southern Medical University evaluating whether plasma sphingolipid metabolit…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer [NA]
This clinical trial compares standard SBRT dosing to radiobiologically-guided SBRT dosing for liver cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy [Phase 2]
Phase 2 trial evaluating the efficacy and safety of radiotherapy for oligoprogressive hepatocellular carcinoma after first-line PD-1 therapy…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma [Phase 3]
A Phase 3 clinical trial comparing transarterial chemoembolization (TACE) alone versus TACE plus stereotactic body radiation therapy (SBRT) …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy [Phase 2]
This clinical trial update reports a Phase II study evaluating HLX43 in patients with locally advanced or metastatic hepatocellular carcinom…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC [Phase 2]
Phase 2 study of HBV-TCR T Cells (LioCyx-M) as monotherapy or with Lenvatinib for HBV-related hepatocellular carcinoma; the trial is not yet…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Yttrium-90 microsphere radioembolization combined with immune checkpoint inhibitors, anti-angiogenesis dru…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
This clinical trial update discusses a noninvasive breath test being studied to detect liver cancer and monitor liver conditions, with recru…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC) [EARLY_Phase 1]
An early-phase Phase 1 clinical trial update noting that recruitment is ongoing for hepatic intra-arterial therapy in hepatocellular carcino…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of activated T lymphocytes (ATL) in hepatocellular carcinoma is currently recruiti…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study
An ongoing prospective cohort study evaluating urine proteomics-based dynamic surveillance to detect early recurrence after radical surgery …
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) [Phase 1]
Phase 1 study evaluating intravenous livmoniplimab in combination with budigalimab in adults with locally advanced or metastatic hepatocellu…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Personalized DC Vaccine for Postoperative Cancer [Phase 1]
A Phase 1 clinical trial evaluating a personalized dendritic cell vaccine for postoperative gastric cancer and hepatocellular carcinoma is c…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating cryoablation in combination with tislelizumab and lenvatinib as second-line or later therapy for adva…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization [Phase 1, Phase 2]
Clinical trial update for FB-1603 in hepatocellular carcinoma patients undergoing transarterial chemoembolization (Phase 1/Phase 2; recruiti…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
This entry notes a Phase I/II clinical trial evaluating AST-3424 in subjects with advanced solid tumors and hepatocellular carcinoma, with t…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma [Phase 3]
This is a Phase 3 clinical trial evaluating HLX13 versus YERVOY as first-line therapy for unresectable hepatocellular carcinoma, focusing on…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 trial evaluating atezolizumab plus bevacizumab, with or without external beam radiotherapy…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials [NA]
This clinical trial update describes diversity and inclusion initiatives in prevention and therapy trials, with ongoing recruitment for stud…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices [NA]
A clinical trial compares carvedilol monotherapy to carvedilol plus endoscopic variceal ligation for primary prevention of variceal bleeding…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Sialic Acid in Hepatocellular Carcinoma
A clinical trial investigating sialic acid in hepatocellular carcinoma is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC [Phase 2]
Phase 2 clinical trial update comparing DEB-TACE plus RALOX-HAIC versus DEB-TACE for large non-resectable hepatocellular carcinoma; currentl…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma [Phase 1, Phase 2]
SCG101 is being studied in a Phase 1/2 trial for hepatitis B virus-related hepatocellular carcinoma. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC [Phase 4]
This Phase 4 trial compares endoscopic variceal ligation versus carvedilol to prevent first esophageal variceal bleeding in patients with he…